How Much Does Crestor (Rosuvastatin) Cost in North Carolina in 2026?

Brand vs. Generic Rosuvastatin Pricing in North Carolina

The price gap between brand Crestor and generic rosuvastatin is one of the widest in the statin class. AstraZeneca's list price sits near $290 per month for a 30-day supply, while generic versions from manufacturers like Aurobindo, Teva, and Accord Healthcare average roughly $15 per month at North Carolina retail chains including CVS, Walgreens, and Harris Teeter pharmacies.

Why the Generic Is So Cheap

Rosuvastatin lost patent exclusivity in 2016, and the FDA's Orange Book now lists more than a dozen approved generic equivalents [1]. That competition pushed retail cash prices below $1 per day in most NC markets. A 2021 analysis in the Journal of the American Heart Association found generic statin adoption saved U.S. Patients an estimated $4.3 billion annually [2].

Retail Price Variation Across NC

Pharmacy-to-pharmacy variation within North Carolina can range from $8 to $25 for a 30-day supply of generic rosuvastatin 10 mg. Independent pharmacies in rural counties (Robeson, Sampson, Bertie) sometimes price generics higher due to lower prescription volume and distributor markups. GoodRx-style discount codes can compress that range, but they do not apply at every independent counter. The FDA-approved prescribing information for rosuvastatin confirms bioequivalence across all approved generics, so therapeutic differences between a $8 tablet and a $25 tablet are negligible [1].

North Carolina Medicaid Coverage for Rosuvastatin

NC Medicaid covers rosuvastatin, but not for the indication most patients need. The state's Preferred Drug List restricts rosuvastatin reimbursement to type 2 diabetes management. Patients prescribed rosuvastatin purely for hyperlipidemia or primary ASCVD prevention do not qualify for Medicaid coverage under current formulary rules.

What That Means in Practice

A patient with both type 2 diabetes and elevated LDL-C can get rosuvastatin covered. A patient with isolated hyperlipidemia cannot. This distinction matters because the 2018 AHA/ACC Cholesterol Guideline recommends high-intensity statins (rosuvastatin 20 to 40 mg) as first-line therapy for patients with clinical ASCVD regardless of diabetes status [3]. North Carolina's Medicaid restriction creates a coverage gap for a large segment of statin-eligible adults.

Workarounds for Medicaid Patients

Prescribers can request a prior authorization for off-formulary use, though approval rates vary by managed care organization. An alternative: atorvastatin 40 to 80 mg sits on NC Medicaid's preferred list without restriction. The SATURN trial (N=1,039) demonstrated comparable atheroma regression between rosuvastatin 40 mg and atorvastatin 80 mg at 24 months, with LDL-C reductions of 37.0% vs. 36.4% respectively [4]. Switching to atorvastatin is clinically reasonable for most Medicaid patients locked out of rosuvastatin coverage.

Insurance Coverage for Crestor Across NC Plans

Most North Carolina commercial insurers cover generic rosuvastatin on Tier 1 with low or zero copay. Brand Crestor is a different story.

Commercial Plan Formulary Tiers

Blue Cross NC, the state's largest insurer, places generic rosuvastatin on Tier 1 (preferred generic) and brand Crestor on Tier 3 (non-preferred brand) with prior authorization required. Aetna and UnitedHealthcare plans sold on the NC ACA marketplace follow a similar pattern. Patients whose physicians specifically prescribe brand Crestor need to demonstrate generic intolerance or therapeutic failure, typically documented via two prior generic statin trials. The ACC Expert Consensus on Nonstatin Therapies outlines statin intolerance criteria that most insurers reference when adjudicating these appeals [5].

Medicare Part D in North Carolina

Medicare Part D plans in NC generally cover generic rosuvastatin without prior authorization. Brand Crestor coverage depends on the plan, with most requiring step therapy through a generic first. During the Part D coverage gap (the "donut hole"), patients pay 25% coinsurance. For a $290 brand-name prescription, that is $72.50 out of pocket per fill. A 2023 CMS analysis reported that statin adherence dropped 12% among Medicare beneficiaries who reached the coverage gap, a finding with direct cardiovascular consequences [6].

State Employee Health Plan

The NC State Health Plan for Teachers and State Employees covers generic rosuvastatin at $0 copay through 90-day mail order. Brand Crestor requires Tier 3 copay ($45 to $75 per fill) plus prior authorization. State employees save the most by using the 90-day mail-order generic option, which typically costs under $12 for a full quarter's supply.

Compounded Rosuvastatin in North Carolina

Compounded rosuvastatin is legal in North Carolina through licensed 503A compounding pharmacies. These pharmacies operate under state Board of Pharmacy oversight and federal section 503A of the FD&C Act, which permits patient-specific compounding with a valid prescription [7].

When Compounding Makes Sense

Compounded rosuvastatin serves patients who cannot tolerate commercial formulations due to specific excipient allergies (lactose, certain dyes) or who need non-standard dosage forms like suspensions or sublingual preparations. The FDA's compounding guidance clarifies that compounded drugs are not FDA-approved and lack bioequivalence data, so prescribers should default to commercial generics when possible [7].

Cost Considerations

Some NC 503A pharmacies advertise compounded rosuvastatin at very low out-of-pocket cost, occasionally near $0 when bundled with telehealth consultation fees. Patients should verify that the pharmacy holds a current NC Board of Pharmacy compounding license and uses USP 795-compliant procedures. The United States Pharmacopeia Chapter 795 standard was updated in 2023 with stricter beyond-use dating and testing requirements [8].

Telehealth Prescribing of Rosuvastatin in NC

North Carolina permits telehealth prescribing of rosuvastatin with no in-person visit requirement for initial prescriptions. The NC Medical Board recognizes synchronous audio-video encounters as sufficient to establish a patient-provider relationship for non-controlled substances.

How the Process Works

A patient in Raleigh, Asheville, or any NC zip code can complete a telehealth visit, receive a rosuvastatin prescription electronically, and fill it at any NC pharmacy. The 2019 ACC/AHA Primary Prevention Guideline recommends a fasting lipid panel and 10-year ASCVD risk calculation before initiating statin therapy [9]. Most telehealth platforms order labs through Quest or Labcorp, both of which have extensive NC draw-site networks.

Monitoring After Initiation

Statin therapy requires follow-up labs. The guideline recommends a fasting lipid panel 4 to 12 weeks after starting or adjusting a statin dose, then every 3 to 12 months thereafter [9]. A hepatic function panel at baseline is standard practice, though the FDA label for rosuvastatin notes that routine liver enzyme monitoring is no longer mandatory in the absence of symptoms [1]. Telehealth follow-ups can handle most of this monitoring without office visits.

Clinical Evidence Supporting Rosuvastatin

Rosuvastatin is one of only two high-intensity statins (the other being atorvastatin 40 to 80 mg). Its evidence base for cardiovascular risk reduction is extensive.

The JUPITER Trial

The landmark JUPITER trial (N=17,802) randomized patients with LDL-C <130 mg/dL and hsCRP ≥2.0 mg/L to rosuvastatin 20 mg or placebo [10]. At a median follow-up of 1.9 years, rosuvastatin reduced the primary composite endpoint of MI, stroke, arterial revascularization, hospitalization for unstable angina, or cardiovascular death by 44% (HR 0.56, 95% CI 0.46 to 0.69). The trial was stopped early for efficacy. LDL-C dropped 50% from baseline.

"The results indicate that rosuvastatin significantly reduced the incidence of major cardiovascular events among apparently healthy persons with elevated C-reactive protein levels," wrote Paul Ridker, MD, lead investigator, in the New England Journal of Medicine [10].

METEOR and Plaque Regression

The METEOR trial (N=984) showed that rosuvastatin 40 mg slowed progression of carotid intima-media thickness (CIMT) compared to placebo in low-risk patients with subclinical atherosclerosis [11]. Mean CIMT change was -0.0014 mm/year with rosuvastatin vs. +0.0131 mm/year with placebo (P<0.001).

Head-to-Head Potency

A meta-analysis published in The Lancet (N=170,000 across 26 trials) established that each 1 mmol/L (39 mg/dL) reduction in LDL-C with statin therapy reduces major vascular events by approximately 22% [12]. Rosuvastatin achieves 45 to 55% LDL-C reduction at the 20 to 40 mg dose range, making it the most potent per-milligram statin available. This compares to 39 to 52% reduction with atorvastatin 40 to 80 mg per the 2018 ACC/AHA guideline's statin intensity table [3].

Discount Programs and Savings Strategies in North Carolina

Several programs can reduce rosuvastatin costs below the $15 average generic cash price.

Manufacturer and Third-Party Cards

AstraZeneca previously offered a brand Crestor savings card that reduced copays to as low as $3 per month for commercially insured patients. Since generic entry, most savings-card programs target the generic product. Pharmacy benefit aggregators (GoodRx, RxSaver, SingleCare) commonly display NC prices between $8 and $14 for a 30-day supply of generic rosuvastatin 10 mg or 20 mg.

NC-Specific Assistance

The North Carolina Association of Free & Charitable Clinics operates more than 70 clinics statewide that provide free or low-cost medications to uninsured patients with incomes below 200% of the federal poverty level. A 2020 study in Circulation found that out-of-pocket statin costs above $10 per month were associated with a 14.6% reduction in adherence among low-income patients [13]. Getting below that threshold matters.

$4 Generic Programs

Walmart, Publix, and some Harris Teeter locations in NC include rosuvastatin on their $4/$10 generic lists (30-day/90-day supply). Availability varies by dose and store, but 5 mg and 10 mg tablets are most commonly stocked at these prices. The AHA's 2024 Scientific Statement on medication affordability emphasized that $4 generic programs are among the most effective interventions for improving statin adherence in underserved populations [14].

Safety Profile and NC-Relevant Considerations

Rosuvastatin is generally well tolerated across all approved doses. The FDA label lists the most common adverse reactions (incidence ≥2%) as headache, myalgia, abdominal pain, asthenia, and nausea [1].

Muscle-Related Side Effects

Myalgia occurs in 2 to 11% of patients depending on the study population. True rhabdomyolysis is rare, at roughly 1 to 3 per 100,000 patient-years. The STOMP trial (N=420) found that high-dose atorvastatin 80 mg did not significantly increase muscle pain or weakness compared to placebo, though it did slightly raise creatine kinase levels [15]. Rosuvastatin-specific myalgia data from JUPITER showed no significant difference from placebo in muscle-related adverse events [10].

Renal Dosing Adjustments

Rosuvastatin 5 mg is the recommended starting dose for patients with severe renal impairment (GFR <30 mL/min), with a maximum of 10 mg daily. This is relevant for NC prescribers because North Carolina has the 12th-highest prevalence of chronic kidney disease in the United States, per CDC chronic disease data [16]. Prescribers should check renal function before starting therapy and adjust accordingly.

"In patients with severe renal impairment not on hemodialysis, dosage of rosuvastatin should be started at 5 mg once daily and not exceed 10 mg once daily," states the FDA-approved prescribing information [1].

How to Get Rosuvastatin at the Lowest Cost in NC

The practical algorithm is straightforward. Start with generic rosuvastatin at a $4 generic program pharmacy if one is nearby. If not, use a discount card at any NC retail pharmacy to target $8 to $15 per month. Confirm your insurance formulary covers generic rosuvastatin at Tier 1. If you are on NC Medicaid and need rosuvastatin for hyperlipidemia rather than diabetes, ask your prescriber about atorvastatin as a covered alternative or request a prior authorization. For patients who need a compounded formulation, verify the 503A pharmacy's NC license status at the NC Board of Pharmacy website before filling.